crizotinib News
Most Popular crizotinib Story
Crizotinib - 10 promising late-stage cancer drugs
The knock on Pfizer's ($PFE) crizotinib is that it only targets a tiny percentage of lung cancer patients, but the important thing is that the drug appears to have an impact for that tiny percentage. Read more...
Latest Headlines
- April 4, 2011
- February 24, 2011
- October 28, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
